Form 6-K Aeterna Zentaris Inc. For: May 11
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________
FORM 6-K
_______________________________
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of May 2015
Commission file number 0-30752
_______________________________
AETERNA ZENTARIS INC.
_______________________________
1405 du Parc-Technologique Boulevard
Quebec City, Québec
Canada, G1P 4P5
(Address of principal executive offices)
_______________________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ý Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes ¨ No ý
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- .
DOCUMENTS INDEX
Documents | Description |
99.1 | Report of Voting Results |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AETERNA ZENTARIS INC. | ||||
Date: May 11, 2015 | By: | /s/ Philip A. Theodore | ||
Philip A. Theodore | ||||
Senior Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary |
Exhibit 99.1
VIA SEDAR
May 11, 2015
To the securities regulatory authorities
of each of the Provinces of Canada
Dear Sirs/Mesdames:
RE: | Aeterna Zentaris Inc. Report of Voting Results pursuant to section 11.3 of National Instrument 51‑102 — Continuous Disclosure Obligations ("NI 51-102") |
Following the annual and special meeting of shareholders of Aeterna Zentaris Inc. (the "Corporation") held on May 8, 2015 (the "Meeting"), and in accordance with Section 11.3 of NI 51‑102, we hereby advise you of the following voting results obtained at the Meeting:
Item Voted Upon | Voting Result | |||
1. | Election of Directors: | l | The nominees proposed by management were elected by a majority of shareholders on a show of hands. The Corporation received proxies with regard to voting on the six directors nominated for election as set forth in the table below: |
Nominee | Votes for | (%) | Votes Withheld | (%) | ||||
Marcel Aubut | 18,128,464 | 94.07 | 1,141,916 | 5.93 | ||||
David A. Dodd | 18,080,446 | 93.83 | 1,189,934 | 6.17 | ||||
Carolyn Egbert | 18,154,579 | 94.21 | 1,115,801 | 5.79 | ||||
Juergen Ernst | 17,913,295 | 92.96 | 1,357,085 | 7.04 | ||||
Pierre Lapalme | 18,123,537 | 94.05 | 1,146,843 | 5.95 | ||||
Gérard Limoges | 18,149,458 | 94.18 | 1,120,922 | 5.82 |
2. | Appointment of PricewaterhouseCoopers LLP as the Corporation's auditors: | l | PricewaterhouseCoopers LLP were appointed as the Corporation's auditors and the directors were authorized to determine their remuneration by a majority of shareholders on a show of hands. | |
3. | A special resolution to authorize and approve the filing of Articles of Amendment to consolidate the issued and outstanding common shares of the Corporation: | l | The resolution described at item 3 hereof authorizing and approving the filing of Articles of Amendment to consolidate the issued and outstanding common shares of the Corporation was approved by 81.08% of the Corporation's shareholders on a vote by way of ballot. |
Trusting the whole is to your satisfaction, we remain,
Yours truly,
(Signed)
Philip A. Theodore
Senior Vice President, Chief Administrative Officer,
General Counsel and Corporate Secretary
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone
- Form 8.5 (EPT/RI) - Accrol Group Holdings Plc
- 3 Essential Tips for a Refreshing Spring Clean with Tineco
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!